AbbVie to Present at the TD Cowen's 45th Annual Health Care Conference
Rhea-AI Summary
AbbVie (NYSE: ABBV) has announced its upcoming participation in TD Cowen's 45th Annual Health Care Conference. The event will take place on Wednesday, March 5, 2025, featuring a management fireside chat scheduled for 8:10 a.m. Central time.
Investors and interested parties can access a live audio webcast of the presentation through AbbVie's Investor Relations website at investors.abbvie.com. An archived version of the session will be made available for viewing later the same day.
Positive
- None.
Negative
- None.
News Market Reaction – ABBV
In the trading session that priced this news, ABBV declined 0.55%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
AI-generated analysis. How Rhea-AI works. Not financial advice.
A live audio webcast of the presentation will be accessible through AbbVie's Investor Relations website at investors.abbvie.com. An archived edition of the session will be available later that day.
About AbbVie
AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas – immunology, oncology, neuroscience, and eye care – and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on LinkedIn, Facebook, Instagram, X (formerly Twitter), and YouTube.
Media: | Investors: |
Gabby Tarbert | Liz Shea |
(224) 244-0111 | (847) 935-2211 |
View original content to download multimedia:https://www.prnewswire.com/news-releases/abbvie-to-present-at-the-td-cowens-45th-annual-health-care-conference-302385335.html
SOURCE AbbVie
